Bone Marrow Transplant Unit, Department of Hematology, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark.
Department of Clinical Immunology, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark.
Scand J Immunol. 2021 Jul;94(1):e13042. doi: 10.1111/sji.13042. Epub 2021 Apr 12.
We aimed to use a novel standardized whole-blood stimulation system to evaluate differences in the functional immune reconstitution in patients early after allogeneic haematopoietic cell transplantation (HCT). Between April and September 2018, 30 patients undergoing HCT had whole blood samples collected around day -21 (day 0 being the day of haematopoietic cell infusion) and day +28. Whole blood was transferred to TruCulture assays comprising prefilled incubation tubes with cell culture medium and a standardized stimulus. We used a panel of four stimuli (lipopolysaccharide, resiquimod, heat-killed Candida albicans and polyinosinic:polycytidylic acid) and a blank, designed to evaluate the function of critical extra- and intracellular immunological signalling pathways. For each stimulus, the cytokine response was assessed by the concentration of interferon-γ, interleukin (IL)-12p40, IL-10, IL-1β, IL-6, IL-8, IL-10, IL-12p40, IL-17A and tumour necrosis factor-α using a multiplex Luminex assay. Pre-HCT cytokine responses were globally decreased across several different stimuli. Despite patients receiving immunosuppressive prophylaxis at the time, post-HCT cytokine responses were higher and less intercorrelated than pre-HCT responses, also after adjusting for differences in the leukocyte differential counts. For the resiquimod and heat-killed Candida albicans stimuli, we identified a cluster of patients in whom post-HCT responses were lower than average across several cytokines, indicating a possible functional immune deficiency. Our findings suggest that the standardized whole blood stimulation system can be used to reveal heterogeneity in the in vitro cytokine responses to various stimuli after HCT. Larger studies are needed to address if the functional immune reconstitution after HCT can predict the risk of infections.
我们旨在使用一种新型标准化全血刺激系统来评估异基因造血细胞移植(HCT)后早期患者的功能性免疫重建差异。在 2018 年 4 月至 9 月期间,30 名接受 HCT 的患者在移植前 21 天(即造血细胞输注日)和移植后 28 天左右采集全血样本。将全血转移到 TruCulture 测定中,其中包含预填充有细胞培养基和标准化刺激物的孵育管。我们使用了四个刺激物(脂多糖、瑞喹莫德、热灭活白色念珠菌和聚肌胞苷酸)和一个空白对照的面板,旨在评估关键的细胞外和细胞内免疫信号通路的功能。对于每个刺激物,通过干扰素-γ、白细胞介素(IL)-12p40、IL-10、IL-1β、IL-6、IL-8、IL-10、IL-12p40、IL-17A 和肿瘤坏死因子-α的浓度来评估细胞因子反应,使用多重 Luminex 测定法。在几个不同的刺激物中,移植前的细胞因子反应普遍降低。尽管患者在接受时接受了免疫抑制预防,但 HCT 后细胞因子反应高于移植前,并且在调整白细胞差异计数的差异后,相关性也较低。对于瑞喹莫德和热灭活白色念珠菌刺激物,我们发现有一群患者的 HCT 后反应低于几种细胞因子的平均水平,表明可能存在功能性免疫缺陷。我们的研究结果表明,标准化全血刺激系统可用于揭示 HCT 后对各种刺激物的体外细胞因子反应的异质性。需要更大的研究来确定 HCT 后功能性免疫重建是否可以预测感染风险。